SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION

Abstract. Post-infection immunity represents an immunogenicity standard for antiviral vaccines, including those against influenza. To estimate the immunogenic properties of vaccine preparations, it is necessary to compare the quantitative and qualitative parameters of immune responses to the vaccine...

Full description

Bibliographic Details
Main Authors: S. A. Donina, A. N. Naikhin, G. D. Petukhova, I. B. Barantseva, T. V. Chirkova, Е. P. Grigor’eva, А. R. Rekstin, L. G. Rudenko
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/419
_version_ 1826534322608275456
author S. A. Donina
A. N. Naikhin
G. D. Petukhova
I. B. Barantseva
T. V. Chirkova
Е. P. Grigor’eva
А. R. Rekstin
L. G. Rudenko
author_facet S. A. Donina
A. N. Naikhin
G. D. Petukhova
I. B. Barantseva
T. V. Chirkova
Е. P. Grigor’eva
А. R. Rekstin
L. G. Rudenko
author_sort S. A. Donina
collection DOAJ
description Abstract. Post-infection immunity represents an immunogenicity standard for antiviral vaccines, including those against influenza. To estimate the immunogenic properties of vaccine preparations, it is necessary to compare the quantitative and qualitative parameters of immune responses to the vaccine strain and the virulent virus from which it is prepared. However, for ethical reasons, such human studies are difficult, because there is the possibility of pathogenic viral infection.The aim of this experimental work was to compare systemic immune responses to the pathogenic mouse influenza virus A (H1N1), and an attenuated reassortant virus, genetic formula 2/6 (R 2/6), an experimental analogue to the live influenza vaccine.It was shown, that R 2/6 lagged behind the pathogenic parental virus (PPV) in activated induction of circulating IgG-antibodies, secretion of a marker Th1-cytokine IFN-γ by splenocytes, and CTL (CD8+) production in the spleen. On the other hand, R 2/6 was highly competitive with PPV, with regard to quantitative proliferative parameters of pooled splenocytes, stimulation of Th (CD4+) cells, B-cells (CD19+), and Th2-cytokine IL-2. IL-6 production in the spleen was poorly induced by both viruses.Thus, attenuation of influenza A (H1N1) virus by the 2/6 genetic reassortment differentially influences the induction of systemic immunity constituents. i.e., some parameters of immune response may be reduced, while others are not altered. When preparing vaccine strains for live influenza vaccines, an attention should be given first of all to increased induction of circulating antibodies that comprise the major components of antiviral immunity.
first_indexed 2024-03-08T05:50:39Z
format Article
id doaj.art-63a2ae7c42e244b8a35ab0f4a8b9a66c
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2025-03-14T02:21:11Z
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-63a2ae7c42e244b8a35ab0f4a8b9a66c2025-03-11T17:59:03ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-0181313610.15789/1563-0625-2006-1-31-36416SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATIONS. A. Donina0A. N. Naikhin1G. D. Petukhova2I. B. Barantseva3T. V. Chirkova4Е. P. Grigor’eva5А. R. Rekstin6L. G. Rudenko7ГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургГУ Научно исследовательский институт экспериментальной медицины РАМН, Санкт ПетербургAbstract. Post-infection immunity represents an immunogenicity standard for antiviral vaccines, including those against influenza. To estimate the immunogenic properties of vaccine preparations, it is necessary to compare the quantitative and qualitative parameters of immune responses to the vaccine strain and the virulent virus from which it is prepared. However, for ethical reasons, such human studies are difficult, because there is the possibility of pathogenic viral infection.The aim of this experimental work was to compare systemic immune responses to the pathogenic mouse influenza virus A (H1N1), and an attenuated reassortant virus, genetic formula 2/6 (R 2/6), an experimental analogue to the live influenza vaccine.It was shown, that R 2/6 lagged behind the pathogenic parental virus (PPV) in activated induction of circulating IgG-antibodies, secretion of a marker Th1-cytokine IFN-γ by splenocytes, and CTL (CD8+) production in the spleen. On the other hand, R 2/6 was highly competitive with PPV, with regard to quantitative proliferative parameters of pooled splenocytes, stimulation of Th (CD4+) cells, B-cells (CD19+), and Th2-cytokine IL-2. IL-6 production in the spleen was poorly induced by both viruses.Thus, attenuation of influenza A (H1N1) virus by the 2/6 genetic reassortment differentially influences the induction of systemic immunity constituents. i.e., some parameters of immune response may be reduced, while others are not altered. When preparing vaccine strains for live influenza vaccines, an attention should be given first of all to increased induction of circulating antibodies that comprise the major components of antiviral immunity.https://www.mimmun.ru/mimmun/article/view/419systemic immune responsesinfluenzavaccination
spellingShingle S. A. Donina
A. N. Naikhin
G. D. Petukhova
I. B. Barantseva
T. V. Chirkova
Е. P. Grigor’eva
А. R. Rekstin
L. G. Rudenko
SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
Медицинская иммунология
systemic immune responses
influenza
vaccination
title SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
title_full SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
title_fullStr SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
title_full_unstemmed SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
title_short SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
title_sort systemic antibody and cellular immune responses in influenza infection and postsvaccination
topic systemic immune responses
influenza
vaccination
url https://www.mimmun.ru/mimmun/article/view/419
work_keys_str_mv AT sadonina systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT annaikhin systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT gdpetukhova systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT ibbarantseva systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT tvchirkova systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT epgrigoreva systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT arrekstin systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination
AT lgrudenko systemicantibodyandcellularimmuneresponsesininfluenzainfectionandpostsvaccination